Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-08-09
1987-10-27
Wiseman, Thomas G.
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 91, 424 92, 514 2, 514 12, 530350, 530362, 530363, 530807, A61K 3900, A61K 3912, A61K 3902, A61K 3936
Patent
active
047029072
ABSTRACT:
By coupling an antigen to a polyphenol derivative the formation of the corresponding antibody can be selectively suppressed by administration thereof to the desired subject.
REFERENCES:
patent: 3794630 (1974-02-01), Mullan et al.
patent: 3825525 (1974-07-01), Mullan et al.
patent: 3893993 (1975-07-01), Mullan et al.
patent: 4140679 (1979-02-01), Malley
patent: 4158705 (1979-06-01), Malley
patent: 4269764 (1981-05-01), Patterson et al.
patent: 4356170 (1982-10-01), Jennings et al.
Becker et al., Am J. Path, vol. 96, pp. 249-254, 1979.
Becker et al., J. Exp. Med., vol. 146(2), 1977, pp. 457-467, "Activation of Factor XII by Tobacco Glycoprotein".
Becker Carl G.
Francus Tova
Siskind Gregory W.
Cornell Research Foundation Inc.
Teskin Robin Lyn
Wiseman Thomas G.
LandOfFree
Process for inducing selective immunosuppression of antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for inducing selective immunosuppression of antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for inducing selective immunosuppression of antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1271354